Ligand Pharmaceuticals (LGND)
NASDAQ: LGND
· Real-Time Price · USD
167.49
0.95 (0.57%)
At close: Sep 04, 2025, 12:14 PM
Kyprolis Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 8.8M | 4.08M | +86.39% |
| Mar 31, 2025 | 4.72M | -72.34M | -93.87% |
| Dec 31, 2024 | 77.06M | 65.47M | +564.40% |
| Sep 30, 2024 | 11.6M | 2.6M | +28.91% |
| Jun 30, 2024 | 9M | 2.37M | +35.68% |
| Mar 31, 2024 | 6.63M | n/a | n/a |
| Dec 31, 2023 | n/a | n/a | n/a |
| Sep 30, 2023 | 23.86M | 3.43M | +16.80% |
| Jun 30, 2023 | 20.43M | 3.28M | +19.10% |
| Mar 31, 2023 | 17.15M | n/a | n/a |
| Dec 31, 2022 | n/a | n/a | n/a |
| Sep 30, 2022 | 19.84M | 1.88M | +10.46% |
| Jun 30, 2022 | 17.96M | 4.26M | +31.14% |
| Mar 31, 2022 | 13.7M | n/a | n/a |
| Dec 31, 2021 | n/a | n/a | n/a |
| Sep 30, 2021 | 15.65M | 7.03M | +81.62% |
| Jun 30, 2021 | 8.62M | 1.5M | +21.15% |
| Mar 31, 2021 | 7.11M | n/a | n/a |
| Dec 31, 2020 | n/a | n/a | n/a |
| Sep 30, 2020 | 9.01M | n/a | n/a |
| Jun 30, 2020 | n/a | n/a | n/a |
| Mar 31, 2020 | n/a | n/a | n/a |
| Jun 30, 2018 | n/a | n/a | n/a |
| Mar 31, 2018 | n/a | n/a | n/a |